JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
JVI Accepts, published online ahead of print on 6 December 2006
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JVI.01310-06v1
81/5/2340    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Werden, S. J.
Right arrow Articles by McFadden, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Werden, S. J.
Right arrow Articles by McFadden, G.

 Previous Article  |  Next Article 

J. Virol. doi:10.1128/JVI.01310-06
Copyright (c) 2006, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

The ankyrin repeat, host range protein of myxoma virus, M-T5, which activates Akt can be functionally replaced by cellular PIKE-A

Steven J. Werden, John W. Barrett, Gen Wang, Marianne M. Stanford, and Grant McFadden*

Department of Microbiology and Immunology, University of Western Ontario and Robarts Research Institute, London, Ontario, Canada

* To whom correspondence should be addressed. Email: mcfadden{at}robarts.ca.


   Abstract

The myxoma virus (MV) ankyrin-repeat host range factor, M-T5, has the ability to bind and activate cellular Akt, leading to permissive MV replication in a variety of diverse human cancer cell lines (Wang et al. 2006. Proc Natl Acad Sci U S A 103:4640-5). The susceptibility of permissive human cancer cells to MV infection is directly correlated with the basal or induced levels of phosphorylated Akt. When M-T5 is deleted from MV, the knockout virus, vMyxT5KO, can no longer productively infect a subset of the human cancer cells (designated Type II) that exhibit little or no endogenous phosphorylated Akt. In searching for a host counterpart of M-T5 we noted sequence similarity of M-T5 to a recently identified ankyrin-repeat cellular binding protein of Akt called PIKE-A. PIKE-A binds and activates the kinase activity of Akt in a GTP-dependent manner and promotes the invasiveness of human cancer cell lines. Here we demonstrate that transfected PIKE-A is able to rescue the ability of vMyxT5KO to productively infect Type II human cancer cells that were previously resistant to infection. As well, cancer cells that were completely non-permissive for both wild-type and vMyxT5KO infection (called Type III) were rendered fully permissive following ectopic expression of PIKE-A. We conclude that the MV M-T5 host range protein is functionally interchangeable with the host PIKE-A protein, and that the activation of host Akt by either M-T5 or PIKE-A is critical for the permissiveness of human cancer cells by MV.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2006 by the American Society for Microbiology. All rights reserved.